Capturing virus evolution by proteomic bioinformatics: Hunting for characteristic mutations in the hepatitis E virus genome

References

• Ikram A, Hakim MS, Zhou JH, Wang W, Peppelenbosch MP, Pan Q. Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus. Virulence. 2017:1–12. doi:10.1080/21505594.2017.1358349. PMID:28727933.
   PubMed Web of Science ®Google Scholar
• Anderson N. Evolutionary significance of virus infection. Nature. 1970;227(5265):1346–47. doi:10.1038/2271346a0. PMID:5455138.
   PubMed Web of Science ®Google Scholar
• Lepine P. On the evolution of fixed strains of rabies virus. J Hyg (Lond). 1938;38(2):180–4. doi:10.1017/S0022172400011013. PMID:20475418.
   PubMedGoogle Scholar
• Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S, et al. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol. 2011;85(15):7523–34. doi:10.1128/JVI.02697-10. PMID:21593162.
   PubMed Web of Science ®Google Scholar
• Farci P, Wollenberg K, Diaz G, Engle RE, Lai ME, Klenerman P, Purcell RH, Pybus OG, Alter HJ. Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proc Natl Acad Sci U S A. 2012;109(36):14562–67. doi:10.1073/pnas.1210592109. PMID:22829669.
   PubMed Web of Science ®Google Scholar
• Murcia PR, Wood JL, Holmes EC. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol. 2011;85(11):5312–22. doi:10.1128/JVI.02619-10. PMID:21430049.
   PubMed Web of Science ®Google Scholar
• Cuypers L, Li G, Libin P, Piampongsant S, Vandamme AM, Theys K. Genetic diversity and selective pressure in hepatitis C virus genotypes 1–6: Significance for direct-acting antiviral treatment and drug resistance. Viruses. 2015;7(9):5018–39. doi:10.3390/v7092857. PMID:26389941.
   PubMed Web of Science ®Google Scholar
• van Tong H, Hoan NX, Wang B, Wedemeyer H, Bock CT, Velavan TP. Hepatitis E virus mutations: Functional and clinical relevance. EBioMedicine. 2016;11:31–42. doi:10.1016/j.ebiom.2016.07.039. PMID:27528267.
   PubMed Web of Science ®Google Scholar
• Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698–709. doi:10.1016/S1473-3099(08)70255-X. PMID:18992406.
   PubMed Web of Science ®Google Scholar
• Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013;33(1):41–9. doi:10.1055/s-0033-1338113. PMID:23564388.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Hepatitis E in the EU/EEA, 2005–2015. Stockholm: ECDC; 2017. doi:10.2900/059144.
   Google Scholar
• Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, Kumar Panda S. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387–94. doi:10.1016/j.jhep.2006.09.016. PMID:17125878.
   PubMed Web of Science ®Google Scholar
• Sultana R, Humayun S. Fetomaternal outcome in acute hepatitis e. J Coll Physicians Surg Pak. 2014;24(2):127–30. PMID:24491009.
   PubMed Web of Science ®Google Scholar
• Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811–17. doi:10.1056/NEJMoa0706992. PMID:18287603.
   PubMed Web of Science ®Google Scholar
• Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025–27. doi:10.1056/NEJMc0903778. PMID:19726781.
   PubMed Web of Science ®Google Scholar
• Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2017;66(5):1082–95. doi:10.1016/j.jhep.2016.11.016. PMID:27913223.
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 2010;139(5):1612–18. doi:10.1053/j.gastro.2010.08.002. PMID:20708006.
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, Selves J, Peron JM, Otal P, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50(5):e30–3. doi:10.1086/650488. PMID:20113176.
   PubMed Web of Science ®Google Scholar
• Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S, Jeffrey G, Cheng W, Pfafferott K, Naidoo K, Chapman R, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol. 2006;80(22):11094–104. doi:10.1128/JVI.00912-06. PMID:17071929.
   PubMed Web of Science ®Google Scholar
• Rauch A, James I, Pfafferott K, Nolan D, Klenerman P, Cheng W, Mollison L, McCaughan G, Shackel N, Jeffrey GP, et al. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology. 2009;50(4):1017–29. doi:10.1002/hep.23101. PMID:19670417.
   PubMed Web of Science ®Google Scholar
• Bang KB, Kim HJ. Management of antiviral drug resistance in chronic hepatitis B. World J Gastroenterol. 2014;20(33):11641–49. doi:10.3748/wjg.v20.i33.11641. PMID:25206270.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436(7053):967–72. doi:10.1038/nature04082. PMID:16107837.
   PubMed Web of Science ®Google Scholar
• Kim S, Han KH, Ahn SH. Hepatitis C virus and antiviral drug resistance. Gut Liver. 2016;10(6):890–95. doi:10.5009/gnl15573. PMID:27784846.
   PubMed Web of Science ®Google Scholar
• Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, Hindes RG, Berrey MM. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med. 2013;368(1):34–44. doi:10.1056/NEJMoa1208953. PMID:23281974.
   PubMed Web of Science ®Google Scholar
• Mishra N, Walimbe AM, Arankalle VA. Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients. Virus Genes. 2013;46(1):47–53. doi:10.1007/s11262-012-0833-7. PMID:23054435.
   PubMed Web of Science ®Google Scholar
• Borkakoti J, Ahmed G, Kar P. Report of a novel C1483W mutation in the hepatitis E virus polymerase in patients with acute liver failure. Infect Genet Evol. 2016;44:51–4. doi:10.1016/j.meegid.2016.06.030. PMID:27320795.
   PubMed Web of Science ®Google Scholar
• Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, Wedemeyer H, Suneetha PV, Neyts J. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology. 2014;147(5):1008–11 e7. doi:10.1053/j.gastro.2014.08.040.
   PubMed Web of Science ®Google Scholar
• Lhomme S, Kamar N, Nicot F, Ducos J, Bismuth M, Garrigue V, Petitjean-Lecherbonnier J, Ollivier I, Alessandri-Gradt E, Goria O, et al. Mutation in the hepatitis E virus polymerase and outcome of ribavirin therapy. Antimicrob Agents Chemother. 2015;60(3):1608–14. doi:10.1128/AAC.02496-15. PMID:26711757.
   PubMed Web of Science ®Google Scholar